The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With mRNA COVID-19 Vaccine.

NCT05043311 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
SARS-CoV-2 Infection

Interventions

BIOLOGICAL: SCTV01C
OTHER: Placebo

Sponsor

Sinocelltech Ltd.